ESR1 and neoplasm: Use of positivity thresholds for detection of each marker by IHC (and for detection of ERBB2/HER2 amplification by fluorescence in situ hybridization) identifies four tumor subtypes, ER+HER2−, ER+HER2+, ER−HER2+ and ER−HER2− [2].